Holen Sie sich die Stockscreener-App
0.3553
2.90%
0.01
Handel nachbörslich:
.35
-0.0053
-1.49%
Schlusskurs vom Vortag:
$0.3453
Offen:
$0.341
24-Stunden-Volumen:
875.26K
Relative Volume:
0.39
Marktkapitalisierung:
$32.26M
Einnahmen:
$1.22M
Nettoeinkommen (Verlust:
$-14.15M
KGV:
-1.3665
EPS:
-0.26
Netto-Cashflow:
$-6.55M
1W Leistung:
+3.08%
1M Leistung:
-6.70%
6M Leistung:
+16.19%
1J Leistung:
-13.13%
1-Tages-Spanne:
$0.3379
$0.3699
1-Wochen-Bereich:
$0.3256
$0.3699
52-Wochen-Spanne:
$0.2525
$0.48
IGC Pharma Inc Stock (IGC) Company Profile
Firmenname
IGC Pharma Inc
Sektor
Branche
Telefon
301-983-0998
Adresse
4336 Montgomery Avenue, Bethesda, MD
Vergleichen Sie IGC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IGC
IGC Pharma Inc
|
0.3553 | 29.61M | 1.22M | -14.15M | -6.55M | -0.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
IGC Pharma Inc Aktie (IGC) Neueste Nachrichten
Understanding IGC Pharma Inc.’s price movement2025 Geopolitical Influence & AI Forecast for Swing Trade Picks - Newser
Trend analysis for IGC Pharma Inc. this weekFree Investment Playbook for Growing Markets - Newser
Can IGC Pharma Inc. stock recover from recent decline2025 Volatility Report & AI Powered Buy/Sell Recommendations - Newser
What makes IGC Pharma Inc. stock price move sharplyCapital Secure Pattern Signal Analysis Sheet - Newser
Risk vs reward if holding onto IGC Pharma Inc.Free Market Surge Signal for Swing Traders - Newser
Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ - GlobeNewswire
Can IGC Pharma Inc. withstand a market correctionMulti-Timeframe Confluence Picks - thegnnews.com
Long term hold vs stop loss in IGC Pharma Inc.High Conviction Screener with Trend Matching - Newser
Chart overlay techniques for tracking IGC Pharma Inc.Free Smart Money Tracking Signal Generator - Newser
Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - SINA HONG KONG LIMITED
Can IGC Pharma Inc. expand its profit marginsRocket Picks with Low Risk - newsyoung.net
Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
New Alzheimer's Drug IGC-M3 Targets Multiple Disease Pathways with 90% Efficacy in Preclinical Tests - Stock Titan
Key metrics from IGC Pharma Inc.’s quarterly dataAI Trend Detection for Entry Timing - Newser
Sector ETF performance correlation with IGC Pharma Inc.Earnings Based Stock Performance Forecast - Newser
Can IGC Pharma Inc. weather a recessionFree Trend Analysis Tool - metrotimes.co.kr
What's driving IGC's earnings surprises recently? - AInvest
Can IGC maintain its Q2 2025 earnings momentum? - AInvest
Using Ichimoku Cloud for IGC Pharma Inc. technicalsFree AI Screening for Swing Trade Picks - Newser
Is IGC Pharma Inc. stock bottoming outTrade Safety Report with Pattern Insights - Newser
What hedge funds are buying IGC Pharma Inc.Positive Free Cash Flow Watch - classian.co.kr
Evaluating IGC Pharma Inc. with trendline analysisFree AI Driven Buy Alert Trade Blueprint - Newser
Key resistance and support levels for IGC Pharma Inc.Capital Protection Strategy With Risk Analysis - Newser
Can a trend reversal in IGC Pharma Inc. lead to recoveryPrice Action Summary and Entry Strategy Guide - Newser
Using economic indicators to assess IGC Pharma Inc. potentialFree Reliable Chart-Based Trade Entries - Newser
IGC Pharma Reports Promising In Vitro Efficacy of IGC-M3 Against Alzheimer's Disease - AInvest
IGC Pharma's IGC-M3 Shows Promise in Alzheimer's Treatment: Targets Key Drivers of Disease Progression - AInvest
IGC Pharma Reports IGC-M3's In Vitro Efficacy Against Alzheimer'sTargeting key Drivers of Disease Progression - ACCESS Newswire
Breakthrough: New Alzheimer's Drug Candidate Targets 4 Disease PathwaysIGC-M3 Shows Early Promise - Stock Titan
Azul secures US$650m backstop to fund Chapter 11 equity raise | IGC SEC FilingForm PRE 14A - Stock Titan
Should I hold or sell IGC Pharma Inc. stock in 2025Capitalize on momentum-driven investment opportunities - Jammu Links News
Does IGC Pharma Inc. stock perform well during market downturnsGain insights from top financial experts - Jammu Links News
Why is IGC Pharma Inc. stock attracting strong analyst attentionMarket-leading profit generation - Jammu Links News
What are analysts’ price targets for IGC Pharma Inc. in the next 12 monthsAchieve rapid returns with smart investment plans - Jammu Links News
Is it the right time to buy IGC Pharma Inc. stockRobust financial gains - Jammu Links News
What drives IGC Pharma Inc. stock priceGet timely market insights for better trades - Jammu Links News
How strong is IGC Pharma Inc. company’s balance sheetBreakthrough profits - Jammu Links News
Is IGC Pharma Inc. stock overvalued or undervaluedHigh-impact investment strategies - Jammu Links News
How volatile is IGC Pharma Inc. stock compared to the marketBuild a winning investment strategy today - Jammu Links News
What institutional investors are buying IGC Pharma Inc. stockBuild wealth steadily with proven strategies - Jammu Links News
How does IGC Pharma Inc. generate profit in a changing economyDynamic investment opportunities - Jammu Links News
What are IGC Pharma Inc. company’s key revenue driversTop Growth Insights For Consistent Profits - jammulinksnews.com
Finanzdaten der IGC Pharma Inc-Aktie (IGC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):